Thermo Fisher Scientific (TMO) Tops Q3 EPS by $1.09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Thermo Fisher Scientific (TMO) PT Raised to $715 at Cowen
October 28, 2021 8:07 AM EDTCowen analyst Dan Brennan raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $715.00 (from $696.00) while maintaining an Outperform rating.
The analyst commented, "TMO reported a good 3Q, with COVID testing a big driver along with healthy organic growth ex-COVID of 10%... More
Thermo Fisher set to benefit from demand for testing kits, vaccines
October 26, 2021 1:22 PM EDTBy Amruta Khandekar and Mrinalika Roy
(Reuters) - Thermo Fisher Scientific Inc's third-quarter profit is likely to get a boost from a rebound in COVID-19 testing due to the highly contagious Delta variant and sustained demand for vaccines against the coronavirus, Wall Street analysts said.
In July, when cases eased in the United States, the company cut its annual sales forecast for COVID-19 tests by $900 million. But the demand has again picked up pace in recent months amid a surge in Delta-led infections.
The world's largest maker of scientific instruments, which also supplies raw materials for COVID-19... More
